CY1118863T1 - Καλλιεργεια κυτταρου θηλαστικου - Google Patents

Καλλιεργεια κυτταρου θηλαστικου

Info

Publication number
CY1118863T1
CY1118863T1 CY20171100366T CY171100366T CY1118863T1 CY 1118863 T1 CY1118863 T1 CY 1118863T1 CY 20171100366 T CY20171100366 T CY 20171100366T CY 171100366 T CY171100366 T CY 171100366T CY 1118863 T1 CY1118863 T1 CY 1118863T1
Authority
CY
Cyprus
Prior art keywords
cultivation
mammalian
provides
achieve
mammalian cells
Prior art date
Application number
CY20171100366T
Other languages
English (en)
Inventor
Brian D Follstad
Rebecca E Mccoy
Arvia E Morris
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46579326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1118863(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of CY1118863T1 publication Critical patent/CY1118863T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Abstract

H εφεύρεση παρέχει μέθοδο για καλλιέργεια κυττάρων θηλαστικού. Η μέθοδος παρέχει μεγαλύτερο έλεγχο επί της ανάπτυξης κυττάρου για να επιτυγχάνεται υψηλός τίτλος προϊόντος κυτταροκαλλιεργειών.
CY20171100366T 2011-07-01 2017-03-22 Καλλιεργεια κυτταρου θηλαστικου CY1118863T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161503737P 2011-07-01 2011-07-01
PCT/US2012/045070 WO2013006479A2 (en) 2011-07-01 2012-06-29 Mammalian cell culture

Publications (1)

Publication Number Publication Date
CY1118863T1 true CY1118863T1 (el) 2018-01-10

Family

ID=46579326

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20171100366T CY1118863T1 (el) 2011-07-01 2017-03-22 Καλλιεργεια κυτταρου θηλαστικου
CY20201100473T CY1123146T1 (el) 2011-07-01 2020-05-25 Καλλιεργεια κυτταρου θηλαστικου

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20201100473T CY1123146T1 (el) 2011-07-01 2020-05-25 Καλλιεργεια κυτταρου θηλαστικου

Country Status (24)

Country Link
US (7) US11292829B2 (el)
EP (2) EP2837680B1 (el)
JP (1) JP5897708B2 (el)
KR (7) KR102358951B1 (el)
CN (2) CN107988166B (el)
AU (5) AU2012279230B2 (el)
BR (2) BR122021007265B1 (el)
CA (2) CA2952347A1 (el)
CL (2) CL2013003792A1 (el)
CY (2) CY1118863T1 (el)
DK (2) DK2837680T3 (el)
EA (1) EA039023B1 (el)
ES (2) ES2625045T3 (el)
HK (2) HK1197081A1 (el)
HU (2) HUE049119T2 (el)
IL (5) IL310968A (el)
LT (2) LT2837680T (el)
MX (1) MX351974B (el)
PL (2) PL2726600T3 (el)
PT (2) PT2837680T (el)
SG (1) SG10201702537RA (el)
SI (2) SI2726600T1 (el)
WO (1) WO2013006479A2 (el)
ZA (1) ZA201309372B (el)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CA2910619A1 (en) 2006-09-13 2008-03-20 Abbvie Inc. Cell culture improvements
CA2738499A1 (en) 2008-10-20 2010-04-29 Abbott Laboratories Viral inactivation during purification of antibodies
TW201024318A (en) 2008-10-20 2010-07-01 Abbott Lab Isolation and purification of antibodies using protein A affinity chromatography
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
EP2837680B1 (en) * 2011-07-01 2020-02-26 Amgen Inc. Mammalian cell culture
TW201325608A (zh) 2011-10-18 2013-07-01 Coherus Biosciences Inc 用糖及多元醇之組合穩定化之依那西普調配物
US10485869B2 (en) 2011-10-18 2019-11-26 Coherus Biosciences, Inc. Etanercept formulations stabilized with meglumine
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
KR20150030704A (ko) 2012-07-09 2015-03-20 코히러스 바이오사이언시즈, 인코포레이티드 육안으로 보이지 않는 입자의 현저한 감소를 나타내는 에타너셉트 제형
AU2013309506A1 (en) 2012-09-02 2015-03-12 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
PL2895188T3 (pl) 2012-09-11 2018-06-29 Coherus Biosciences, Inc. Prawidłowo pofałdowany etanercept o wysokiej czystości i doskonałej wydajności
US20140199728A1 (en) * 2013-01-14 2014-07-17 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
TWI720289B (zh) 2013-03-14 2021-03-01 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
CA2907771C (en) * 2013-03-26 2023-01-10 Coherus Biosciences, Inc. Perfusion method for manufacturing etanercept
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
MX2016005572A (es) * 2013-10-31 2016-12-09 Amgen Inc Uso de monensina para regular la glicosilacion de proteinas recombinantes.
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2015095809A1 (en) 2013-12-20 2015-06-25 Biogen Idec Ma Inc. Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality
CN106029896B (zh) 2014-01-13 2020-10-27 美国安进公司 调控鸟氨酸代谢以操控重组蛋白的高甘露糖糖型含量
ES2784775T3 (es) 2014-01-30 2020-09-30 Coherus Biosciences Inc Medios de perfusión
KR102391259B1 (ko) * 2014-06-04 2022-04-26 암젠 인크 포유류 세포 배양물을 회수하는 방법
TWI743024B (zh) 2014-06-06 2021-10-21 美商健臻公司 灌注培養方法及其用途
TWI776235B (zh) * 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
JP6530171B2 (ja) * 2014-09-09 2019-06-12 旭化成メディカル株式会社 培養産生物の回収方法
SG10202002458PA (en) * 2014-12-01 2020-04-29 Amgen Inc Process for manipulating the level of glycan content of a glycoprotein
KR102007930B1 (ko) * 2014-12-31 2019-08-06 주식회사 엘지화학 재조합 당단백질의 글리코실화 조절 방법
CN105385731B (zh) * 2015-12-25 2018-10-30 上海莱士血液制品股份有限公司 一种表达重组八因子的灌注培养方法
CN109153717A (zh) * 2016-01-06 2019-01-04 安口生物公司 减少单克隆抗体组合物中的高分子量物类、酸性电荷物类和片段
CN109563161A (zh) 2016-02-03 2019-04-02 安口生物公司 用于提高抗体稳定性的缓冲制剂
WO2017149065A1 (en) 2016-03-02 2017-09-08 Lonza Ltd Improved fermentation process
US20200377918A1 (en) * 2017-03-31 2020-12-03 Boehringer Ingelheim International Gmbh Perfusion medium
US11702628B2 (en) 2017-03-31 2023-07-18 Boehringer Ingelheim International Gmbh Perfusion medium for culturing mammalian cells and reducing cell bleed in a perfusion cell culture
MA49979A (fr) 2017-08-09 2020-06-17 Juno Therapeutics Inc Procédés de production de compositions de cellules génétiquement modifiées et compositions associées
JP7323512B2 (ja) 2017-10-06 2023-08-08 ロンザ リミテッド ラマン分光法を使用する細胞培養の自動制御
CN111212899A (zh) 2017-10-16 2020-05-29 里珍纳龙药品有限公司 灌注生物反应器及相关使用方法
MA51114A (fr) * 2017-12-08 2020-10-14 Juno Therapeutics Inc Procédé de production d'une compositions de lymphocytes t modifiés
KR20210096671A (ko) * 2018-12-31 2021-08-05 리플리겐 코포레이션 소수성 중공 섬유에 의한 포유류 세포 배양물의 관류 및 정화용 필터
JP2023537760A (ja) * 2020-08-14 2023-09-05 ブリストル－マイヤーズ スクイブ カンパニー タンパク質の製造工程
TW202225398A (zh) * 2020-08-31 2022-07-01 美商再生元醫藥公司 用以改良細胞培養效能及減少天冬醯胺序列變異之天冬醯胺饋料策略
CN114574430A (zh) * 2022-03-22 2022-06-03 成都博宠生物科技有限公司 一种Expi293F细胞培养方法
CN115287251A (zh) * 2022-08-25 2022-11-04 无锡药明生物技术股份有限公司 间歇性灌流联合分批流加培养
WO2024054414A1 (en) 2022-09-06 2024-03-14 Amgen Inc. Lean perfusion cell culture methods
WO2024059235A2 (en) 2022-09-16 2024-03-21 Amgen Inc. A method for harvesting products from perfusion cultures
CN116790483B (zh) * 2023-08-22 2023-10-20 苏州依科赛生物科技股份有限公司 一种cho细胞无血清培养基及其应用

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4499064A (en) 1982-06-03 1985-02-12 Clayton Foundation For Research Assessment of nutritional status of individuals
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US4816401A (en) * 1985-09-09 1989-03-28 University Of Rochester Serum free cell culture medium
US5045468A (en) 1986-12-12 1991-09-03 Cell Enterprises, Inc. Protein-free culture medium which promotes hybridoma growth
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE10399023I2 (de) 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5292655A (en) * 1990-01-29 1994-03-08 Wille Jr John J Method for the formation of a histologically-complete skin substitute
US7037721B1 (en) * 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
GB9118664D0 (en) 1991-08-30 1991-10-16 Celltech Ltd Cell culture
ATE240394T1 (de) 1992-10-23 2003-05-15 Immunex Corp Methoden zur herstellung löslicher, oligomerer proteine
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6310185B1 (en) 1994-03-08 2001-10-30 Memorial Sloan Kettering Cancer Center Recombinant human anti-Lewis Y antibodies
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
DE69635480T2 (de) 1995-06-29 2006-08-17 Immunex Corp., Thousand Oaks Apoptosis induzierendes cytokin
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
EP2218775B1 (en) 1996-08-30 2015-01-28 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
WO2001036637A1 (en) 1999-11-17 2001-05-25 Immunex Corporation Receptor activator of nf-kappa b
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US20030036505A1 (en) 2000-09-25 2003-02-20 Human Genome Sciences, Inc. Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon
JP2004532642A (ja) 2001-06-13 2004-10-28 ジェネンテック・インコーポレーテッド 動物細胞の培養方法と動物細胞でのポリペプチド産生
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
AU2003220529B2 (en) 2002-03-27 2006-09-07 Immunex Corporation Methods for increasing polypeptide production
WO2005095578A1 (en) * 2004-03-05 2005-10-13 Dsm Ip Assets B.V. Process for cell culturing by continuous perfusion and alternating tangential flow
CN1332024C (zh) * 2004-06-09 2007-08-15 中国科学院大连化学物理研究所 一种海绵细胞的微载体三维培养方法
EP1765427B1 (en) 2004-07-07 2010-04-21 Coloplast A/S Preparation of hydrophilic coatings utilizing a 1,3-dioxolane compound
TWI374935B (en) * 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
JP2008518597A (ja) * 2004-10-29 2008-06-05 セントカー・インコーポレーテツド 化学的規定培地組成物
PT2267024E (pt) * 2005-06-03 2012-06-01 Ares Trading Sa Produção de proteína de ligação a il-18 recombinante
HUE034299T2 (en) 2006-07-14 2018-02-28 Patheon Holdings I B V An improved method for cell culture
WO2008024769A2 (en) * 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
KR101523782B1 (ko) 2006-11-08 2015-05-28 와이어쓰 엘엘씨 세포 배양을 위한 합리적으로 설계된 배지
US20100221823A1 (en) 2007-06-11 2010-09-02 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
EP3327132A3 (en) 2007-08-09 2018-07-18 Wyeth LLC Use of perfusion to enhance production of fed-batch cell culture in bioreactors
JP5524214B2 (ja) 2008-09-15 2014-06-18 ジェネンテック， インコーポレイテッド 細胞容積モル浸透圧濃度を調節するための組成物および方法
CN101603026B (zh) * 2009-06-19 2011-01-19 华东理工大学 适于动物细胞产品生产的无动物来源低蛋白培养基
US8580554B2 (en) 2009-07-31 2013-11-12 Baxter International Inc. Method of producing a polypeptide or virus of interest in a continuous cell culture
KR101573972B1 (ko) 2009-07-31 2015-12-02 백스터 인터내셔널 인코포레이티드 Ａｄａｍｔｓ 단백질 발현을 위한 세포 배양 배지
CN104059955A (zh) 2009-08-11 2014-09-24 弗·哈夫曼-拉罗切有限公司 在无谷氨酰胺的细胞培养基中的蛋白质生产
LT2501822T (lt) 2009-11-17 2017-10-25 E. R. Squibb & Sons, L.L.C. Padidintos baltymų produkcijos būdai
WO2011065940A1 (en) 2009-11-24 2011-06-03 Biogen Idec Ma Inc. Method of supplementing culture media to prevent undesirable amino acid substitutions
AU2011324870B2 (en) * 2010-11-01 2015-01-29 Symphogen A/S pan-HER antibody composition
US9133493B2 (en) * 2011-04-21 2015-09-15 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
EP2837680B1 (en) * 2011-07-01 2020-02-26 Amgen Inc. Mammalian cell culture
TWI720289B (zh) 2013-03-14 2021-03-01 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
MX2016005572A (es) 2013-10-31 2016-12-09 Amgen Inc Uso de monensina para regular la glicosilacion de proteinas recombinantes.
RU2761633C2 (ru) * 2015-11-17 2021-12-13 Пфайзер Инк. Среды и способы ферментации для производства полисахаридов в бактериальной клеточной культуре

Also Published As

Publication number Publication date
SI2726600T1 (sl) 2017-07-31
MX2013014937A (es) 2014-04-16
KR20240005106A (ko) 2024-01-11
HK1206057A1 (en) 2015-12-31
ZA201309372B (en) 2014-08-27
US20230129523A1 (en) 2023-04-27
PT2837680T (pt) 2020-04-17
KR101857380B1 (ko) 2018-05-11
PL2837680T3 (pl) 2020-08-10
US11673941B2 (en) 2023-06-13
IL310968A (en) 2024-04-01
US20210061888A1 (en) 2021-03-04
CY1123146T1 (el) 2021-12-31
HUE049119T2 (hu) 2020-09-28
EP2726600A2 (en) 2014-05-07
HK1197081A1 (en) 2015-01-02
BR112013033730A2 (pt) 2017-01-31
SI2837680T1 (sl) 2020-07-31
AU2016244255A1 (en) 2016-10-27
KR101662412B1 (ko) 2016-10-04
CN103827292B (zh) 2018-01-26
IL229803B (en) 2020-11-30
US20220185869A1 (en) 2022-06-16
EP2837680B1 (en) 2020-02-26
CN107988166A (zh) 2018-05-04
IL288509B (en) 2022-12-01
KR102108663B1 (ko) 2020-05-07
LT2837680T (lt) 2020-07-10
KR102558247B1 (ko) 2023-07-24
KR20230114317A (ko) 2023-08-01
KR102358951B1 (ko) 2022-02-08
AU2020281075A1 (en) 2021-01-07
BR122021007265B1 (pt) 2022-02-22
US20230227535A1 (en) 2023-07-20
US20230117598A1 (en) 2023-04-20
US11827692B2 (en) 2023-11-28
US11685772B2 (en) 2023-06-27
EP2726600B1 (en) 2017-02-15
HUE033279T2 (en) 2017-11-28
CN103827292A (zh) 2014-05-28
IL297998A (en) 2023-01-01
AU2020281075B2 (en) 2022-12-22
ES2788132T3 (es) 2020-10-20
KR20180050433A (ko) 2018-05-14
AU2012279230B2 (en) 2016-08-18
US20200407427A1 (en) 2020-12-31
CA2838695C (en) 2017-02-14
EP2837680A1 (en) 2015-02-18
MX351974B (es) 2017-11-06
KR20200051046A (ko) 2020-05-12
KR20160075814A (ko) 2016-06-29
AU2018203972A1 (en) 2018-06-21
KR20140031375A (ko) 2014-03-12
WO2013006479A3 (en) 2013-03-28
CA2838695A1 (en) 2013-01-10
WO2013006479A2 (en) 2013-01-10
BR112013033730B1 (pt) 2022-01-25
AU2012279230A1 (en) 2014-01-09
CL2016001190A1 (es) 2017-06-09
CN107988166B (zh) 2022-03-15
ES2625045T3 (es) 2017-07-18
JP2014520534A (ja) 2014-08-25
US20140255993A1 (en) 2014-09-11
IL288509B2 (en) 2023-04-01
CL2013003792A1 (es) 2014-07-25
DK2837680T3 (da) 2020-04-27
IL297998B1 (en) 2024-03-01
EA201391826A1 (ru) 2014-04-30
PT2726600T (pt) 2017-04-24
US11292829B2 (en) 2022-04-05
IL288509A (en) 2022-01-01
IL278430B (en) 2022-01-01
PL2726600T3 (pl) 2017-08-31
SG10201702537RA (en) 2017-04-27
KR20220021008A (ko) 2022-02-21
DK2726600T3 (en) 2017-05-15
AU2023201127A1 (en) 2023-03-30
US11634476B2 (en) 2023-04-25
JP5897708B2 (ja) 2016-03-30
LT2726600T (lt) 2017-05-25
EA039023B1 (ru) 2021-11-23
AU2018203972B2 (en) 2020-09-17
CA2952347A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
CY1123146T1 (el) Καλλιεργεια κυτταρου θηλαστικου
BR112012005844A2 (pt) Método para cultivar microalgas capazes de crescimento heterotrófico, método para fabricar um material, e sistema de biorreator
EA201171018A1 (ru) Биореактор для культивирования клеток млекопитающих
GB201000593D0 (en) Photo-bioreactor and method for cultivating biomass by photosynthesis
EP2982742A4 (en) PHOTOBIOREACTOR FOR THE MASS CULTIVATION OF PHOTOSYNTHESEMICROORGANISM
MX351511B (es) Composiciones,articulos, aparatos, metodos y sistemas relativos a biomasa de algas.
SG10201810830UA (en) Cell culture compositions and methods for polypeptide production
ZA201403678B (en) Methods and systems for growing plants using silicate-based substrates,cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives ,and formulations,processes and systems for the same
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
EA201491785A1 (ru) Способ ферментации
EA201490945A1 (ru) Набор, содержащий заменитель сыворотки и лабильные факторы
GB2482612B (en) Cell culture support for culturing mesenchymal stem cells
MX2018004580A (es) Metodo para producir proteina de fusion con dominio fc de igg.
IN2014DN09097A (el)
EA200900984A1 (ru) Улучшение клеточного роста
EA201370151A1 (ru) Высокопродуктивная суспензионная клеточная линия, система и способ ее получения
EP2695934A4 (en) CULTURE KIT FOR ANIMAL CELLS, METHOD FOR LIVING ANIMAL CELLS, METHOD FOR SELECTIVATING LIVESTOCK CELLS AND CELL DIFFERENTIATION METHOD
FR2940315B1 (fr) Nouveau procede de culture de levures du genre yarrowia
FR2979182B1 (fr) Serre mobile pour la culture de plantes
GB202011948D0 (en) Bioreactor for cell culture
UA65507U (ru) Способ получения культивируемых лимбальных клеток
TWM439058U (en) Combination of seed culture and culturing matrix necessary for cultivating microorganism